Table 2.
Meta-analysis results of secondary outcomes.
Outcomes | Studies analyzed | Effect size (95% CI) | P-value | I2 |
---|---|---|---|---|
Length of Hospitalization | 9 | SMD: −0.45 (0.92–0.02) | 0.06 | 91% |
MV Duration | 5 | SMD: −0.54 (−1.67–0.59) | 0.35 | 93% |
Complications related to treatment | 4 | RR: 1.03 (0.71–1.48) | 0.99 | 0% |
Discontinuation | 3 | RR: 0.22 (0.06–0.88) | 0.03 | 19% |
Relapse | 3 | RR: 0.47 (0.20–1.14) | 0.10 | 0% |